Michael I. Kotlikoff became Dean of the College of Veterinary Medicine at Cornell University on July 1, 2007. He is the 10th dean of veterinary medicine at Cornell University since 1868 when Cornell became the first university in America to teach the subject.
Dr. Kotlikoff received his V.M.D. degree from the University of Pennsylvania in 1981 and Ph.D. in Physiology from the University of California, Davis in 1984. Before becoming dean, he served as Chair of the Department of Biomedical Sciences from 2000 to 2007. Prior to Cornell, he was Assistant Professor, Associate Professor, Professor and then Chair of the Department of Animal Biology at the School of Veterinary Medicine and Department of Medicine at the University of Pennsylvania.
At Cornell, Dr. Kotlikoff chaired the Mammalian Genomics Life Science Initiative, established and served as the first Director of the Cornell Core Transgenic Mouse Facility, chaired the Provost's Local Advisory Committee of the faculty, and has served on the Institute for Biotechnology and Life Science Technologies Scientific Advisory Committee, the Neurosciences Steering Committee, the Steering Committee for Cell and Molecular Neurobiology, the East Campus Research Facility Executive Committee, the Advisory Committee for Cornell’s Developmental Resource for Biophysical Imaging Opto-Electronics, the Provost’s Graduate Field Task Force, and the Cell and Molecular Neurobiology training grant Executive Committee. He is currently a Senior Editor on the Editorial Board of the Journal of Physiology, serves on the Council on Research at the AVMA, and Chairs the Board of Scientific Councillors of the National Heart, Lung, and Blood Institute of the National Institutes of Health.
In addition to his administrative position, Dr. Kotlikoff continues to run his laboratory, which investigates cardiac and smooth muscle biology. His laboratory has pioneered genetic methods to advance the understanding of cardiovascular disease and the understanding of the molecular basis of cardiac and smooth muscle function. His lab has pioneered the use of purpose -designed fluorescent proteins as calcium sensors to examine cell signaling in vivo at the molecular level. His recent work has focussed on the use of cell and gene –based therapy in the heart, and the processes of repair in the adult and neonatal heart.